PTGX
Protagonist Therapeutics Inc
139.90$
-0.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | +54.1% | -99.3% | +12,293.1% | -4.4% | -2.8% | +125.7% | +624.1% | -89.4% | |
| – | – | +28.3% | +18,055.8% | -100.0% | – | – | – | -62.8% | +220.9% | -10.5% | -58.7% | |
| – | – | – | – | +54.1% | -99.3% | +12,293.1% | -4.4% | -2.8% | +125.7% | +624.1% | -89.7% | |
| – | +58.6% | +117.3% | +79.7% | +28.8% | +9.3% | +16.9% | +65.8% | +0.2% | -4.8% | +15.0% | +15.3% | |
| – | +59.3% | +134.9% | +69.2% | +16.3% | +15.0% | +18.3% | +45.9% | +16.7% | +5.5% | +29.8% | +3.2% | |
| – | +58.8% | +120.8% | +77.4% | +26.3% | +10.3% | +15.3% | +64.5% | +3.1% | -2.7% | +18.2% | +11.7% | |
| – | – | – | – | – | – | – | – | – | – | – | -162.5% | |
| – | – | – | – | – | – | +253.8% | +314.9% | +35.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -146.3% | |
| – | -96.3% | +6,400.0% | -109.8% | – | – | – | -324.1% | – | – | – | -80.1% | |
| – | – | – | – | – | – | – | – | – | – | – | -147.3% | |
| – | – | – | – | – | – | – | – | – | – | – | -145.3% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.